Project Grant HT9425261E310
Award Date 9/1/26
Completion Date 8/31/29
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- Federal Project Grant Award Summary The Defense Health Agency awarded a $311,141 Project Grant to The Johns Hopkins University effective September 1, 2026 through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The research project, titled "Leveraging Germline and Somatic ATM Status in Patients with Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma," will be conducted at the Baltimore, Maryland location. This...
- Federal Grant Award Summary The Johns Hopkins University received a $610,059 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025 through June 30, 2028. The award supports research investigating "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis," which addresses critical gaps in understanding how age-related changes in the tumor microenvironment contribute to pancreatic...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a Project Grant totaling $776,831 under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award supports research on P2 purinergic receptors in pancreatic ductal adenocarcinoma as therapeutic targets, conducted at the institution's Baltimore, Maryland facility. This three-year research initiative represents DHA's investment...
- Federal Project Grant Award Summary The Johns Hopkins University received a $388,194 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025 through June 30, 2028. The award supports research investigating "The Aging Microenvironment as a Driver of Pancreatic Cancer Metastasis," conducted at the institution's Baltimore, Maryland location. This three-year research initiative aligns with...
- Federal Grant Award Summary The Johns Hopkins University received a $232,878 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2025 through May 31, 2027. The award supports research exploring the role of epitranscriptomics in the evolution of neuroendocrine prostate cancer, conducted at the institution's Baltimore, Maryland facility. This research initiative contributes to the DHA's broader mission of...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a $560,000 Project Grant effective September 15, 2026, through September 14, 2028, under the Military Medical Research and Development program (CFDA 12.420). The project, titled "Targeting the Nascent Polypeptide-Associated Complex (NAC) to Block Oncogenic Myristoylation in Diffuse Large B-Cell Lymphoma," involves investigator-initiated biomedical research focused on understanding...
- Federal Grant Award Summary The Johns Hopkins University received a $823,267 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award funds research investigating mitochondrial heteroplasmy as a novel risk factor for myelodysplastic syndromes, a three-year biomedical research initiative conducted at the institution's Baltimore, Maryland facility. This research...
- Federal Project Grant Award Summary The Johns Hopkins University received a $1,349,813 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2028. The award supports research on noninvasive approaches for lung cancer detection, monitoring, and interception. This research initiative aligns with the Defense Health Agency's mission to transform healthcare for military service...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Johns Hopkins University a Project Grant of $1,553,332 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the impact of breast tissue microbiota on breast cancer progression. The award, effective October 1, 2025 through September 30, 2028, supports basic and applied biomedical research addressing health conditions affecting the military population and the American public....
- Federal Grant Award Summary The Johns Hopkins University received a $465,750 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective July 1, 2025 through June 30, 2027. The award supports research investigating estrogen receptor mutations as a novel biomarker for response to endocrine therapy in ovarian cancer. This research contributes to the DHA's mission to transform healthcare for service members and the...